GSK-Vir antibody COVID-19 therapy to be tested in large UK study
(Reuters) – GSK and Vir Biotechnology’s antibody-based COVID-19 drug is being studied as a possible treatment for hospitalised patients in a large British study looking into coronavirus therapies, researchers said on Thursday. The RECOVERY trial will test sotrovimab as the Omicron variant spreads, its website said, with an “urgent need to evaluate alternative therapies.” The …
GSK-Vir antibody COVID-19 therapy to be tested in large UK study Read More »